Downstream Process Development Associate Ii
Current- Expanded role in the second Phase I project by coordinating and executing 50L Confirmation and 200L Demonstration runs to provide process scale-up data and non-GMP BDS for multiple pre-clinical studies.
- Authored process description document for future large-scale campaigns and process development report for the second Phase I project.
- Executed two viral clearance studies using both naïve and aged chromatography resin, and impurity clearance studies for a second Phase III project, followed by timely delivery of summary reports for each of the three.
- Utilized JMP 17 software for the analysis of DoE experiments to identify critical process parameters and set target ranges for critical quality attributes in each unit operation, leading to the completion of impact.
- Delivered a seminar to upwards of 100 KBI employees from several different departments on DSPD approach and results from the two Phase I development projects